カテゴリ： 世界, 医療/バイオ, QYResearch

結膜炎治療薬の世界市場2023年：抗生物質、肥満細胞安定剤、コルチコステロイド、その他

■ 英語タイトル：Global Conjunctivitis Treatment Drugs Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8727）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8727
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：102
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[結膜炎治療薬の世界市場2023年：抗生物質、肥満細胞安定剤、コルチコステロイド、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料は結膜炎治療薬のグローバル市場について調査・分析し、世界の結膜炎治療薬市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（抗生物質、肥満細胞安定剤、コルチコステロイド、その他）、用途別セグメント分析（病院、診療所、医療機関、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Bausch & Lomb Inc、Pfizer Inc、Merck & Co., Inc、Sanofi-Aventis、Boehringer Ingelheim GmbH、Allergan Inc、Novartis AG、Atopix Therapeutics Ltd、Sirion Therapeutics, Inc、Akorn Incorporated、Actavis Generics、Sun Pharma Advanced Research Company Ltd、Sinqi、Santen Pharmaceuticals Co. Ltd、Auven Therapeutics、Alconなどが含まれています。結膜炎治療薬のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、結膜炎治療薬市場規模を算出する際に考慮しました。

・結膜炎治療薬市場の概要
- 製品の定義
- 結膜炎治療薬の種類別セグメント
- 世界の結膜炎治療薬市場規模：タイプ別分析（抗生物質、肥満細胞安定剤、コルチコステロイド、その他）
- 結膜炎治療薬の用途別セグメント
- 世界の結膜炎治療薬市場規模：用途別分析（病院、診療所、医療機関、その他）
- 世界の結膜炎治療薬市場規模予測（2018年-2029年）
- 結膜炎治療薬の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 結膜炎治療薬市場の競争状況およびトレンド

・結膜炎治療薬の地域別市場規模
- 北米の結膜炎治療薬市場規模（2018年-2029年）
- 米国の結膜炎治療薬市場規模（2018年-2029年）
- ヨーロッパの結膜炎治療薬市場規模（2018年-2029年）
- アジア太平洋の結膜炎治療薬市場規模（2018年-2029年）
- 中国の結膜炎治療薬市場規模（2018年-2029年）
- 日本の結膜炎治療薬市場規模（2018年-2029年）
- 韓国の結膜炎治療薬市場規模（2018年-2029年）
- インドの結膜炎治療薬市場規模（2018年-2029年）
- オーストラリアの結膜炎治療薬市場規模（2018年-2029年）
- 中南米の結膜炎治療薬市場規模（2018年-2029年）
- 中東・アフリカの結膜炎治療薬市場規模（2018年-2029年）

・種類別セグメント：抗生物質、肥満細胞安定剤、コルチコステロイド、その他
- 世界の結膜炎治療薬のタイプ別販売量（2018年-2023年）
- 世界の結膜炎治療薬のタイプ別売上（2018年-2023年）
- 世界の結膜炎治療薬のタイプ別価格

・用途別セグメント：病院、診療所、医療機関、その他
- 世界の結膜炎治療薬の用途別販売量（2018年-2023年）
- 世界の結膜炎治療薬の用途別売上（2018年-2023年）
- 世界の結膜炎治療薬の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Bausch & Lomb Inc、Pfizer Inc、Merck & Co., Inc、Sanofi-Aventis、Boehringer Ingelheim GmbH、Allergan Inc、Novartis AG、Atopix Therapeutics Ltd、Sirion Therapeutics, Inc、Akorn Incorporated、Actavis Generics、Sun Pharma Advanced Research Company Ltd、Sinqi、Santen Pharmaceuticals Co. Ltd、Auven Therapeutics、Alcon

・産業チェーンと販売チャネルの分析
- 結膜炎治療薬産業チェーン分析
- 結膜炎治療薬の主要原材料
- 結膜炎治療薬の販売チャネル
- 結膜炎治療薬のディストリビューター
- 結膜炎治療薬の主要顧客

・結膜炎治療薬市場ダイナミクス
- 結膜炎治療薬の業界動向
- 結膜炎治療薬市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Conjunctivitis Treatment Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Conjunctivitis Treatment Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Conjunctivitis Treatment Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Conjunctivitis Treatment Drugs include Bausch & Lomb Inc, Pfizer Inc, Merck & Co., Inc, Sanofi-Aventis, Boehringer Ingelheim GmbH, Allergan Inc, Novartis AG, Atopix Therapeutics Ltd and Sirion Therapeutics, Inc, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Conjunctivitis Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Conjunctivitis Treatment Drugs.
The Conjunctivitis Treatment Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Conjunctivitis Treatment Drugs market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Conjunctivitis Treatment Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Bausch & Lomb Inc
Pfizer Inc
Merck & Co., Inc
Sanofi-Aventis
Boehringer Ingelheim GmbH
Allergan Inc
Novartis AG
Atopix Therapeutics Ltd
Sirion Therapeutics, Inc
Akorn Incorporated
Actavis Generics
Sun Pharma Advanced Research Company Ltd
Sinqi
Santen Pharmaceuticals Co. Ltd
Auven Therapeutics
Alcon
Segment by Type
Antibiotic
Mast Cell Stabilizer
Corticosteroids
Others
Segment by Application
Hospital
Clinic
Medical Institutions
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Conjunctivitis Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Conjunctivitis Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Conjunctivitis Treatment Drugs Market Overview
1.1 Product Overview and Scope of Conjunctivitis Treatment Drugs
1.2 Conjunctivitis Treatment Drugs Segment by Type
1.2.1 Global Conjunctivitis Treatment Drugs Market Value Comparison by Type (2023-2029)
1.2.2 Antibiotic
1.2.3 Mast Cell Stabilizer
1.2.4 Corticosteroids
1.2.5 Others
1.3 Conjunctivitis Treatment Drugs Segment by Application
1.3.1 Global Conjunctivitis Treatment Drugs Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Institutions
1.3.5 Others
1.4 Global Conjunctivitis Treatment Drugs Market Size Estimates and Forecasts
1.4.1 Global Conjunctivitis Treatment Drugs Revenue 2018-2029
1.4.2 Global Conjunctivitis Treatment Drugs Sales 2018-2029
1.4.3 Global Conjunctivitis Treatment Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Conjunctivitis Treatment Drugs Market Competition by Manufacturers
2.1 Global Conjunctivitis Treatment Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Conjunctivitis Treatment Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Conjunctivitis Treatment Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Conjunctivitis Treatment Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Conjunctivitis Treatment Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Conjunctivitis Treatment Drugs, Product Type & Application
2.7 Conjunctivitis Treatment Drugs Market Competitive Situation and Trends
2.7.1 Conjunctivitis Treatment Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Conjunctivitis Treatment Drugs Players Market Share by Revenue
2.7.3 Global Conjunctivitis Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Conjunctivitis Treatment Drugs Retrospective Market Scenario by Region
3.1 Global Conjunctivitis Treatment Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Conjunctivitis Treatment Drugs Global Conjunctivitis Treatment Drugs Sales by Region: 2018-2029
3.2.1 Global Conjunctivitis Treatment Drugs Sales by Region: 2018-2023
3.2.2 Global Conjunctivitis Treatment Drugs Sales by Region: 2024-2029
3.3 Global Conjunctivitis Treatment Drugs Global Conjunctivitis Treatment Drugs Revenue by Region: 2018-2029
3.3.1 Global Conjunctivitis Treatment Drugs Revenue by Region: 2018-2023
3.3.2 Global Conjunctivitis Treatment Drugs Revenue by Region: 2024-2029
3.4 North America Conjunctivitis Treatment Drugs Market Facts & Figures by Country
3.4.1 North America Conjunctivitis Treatment Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Conjunctivitis Treatment Drugs Sales by Country (2018-2029)
3.4.3 North America Conjunctivitis Treatment Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Conjunctivitis Treatment Drugs Market Facts & Figures by Country
3.5.1 Europe Conjunctivitis Treatment Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Conjunctivitis Treatment Drugs Sales by Country (2018-2029)
3.5.3 Europe Conjunctivitis Treatment Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Conjunctivitis Treatment Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Conjunctivitis Treatment Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Conjunctivitis Treatment Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Conjunctivitis Treatment Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Conjunctivitis Treatment Drugs Market Facts & Figures by Country
3.7.1 Latin America Conjunctivitis Treatment Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Conjunctivitis Treatment Drugs Sales by Country (2018-2029)
3.7.3 Latin America Conjunctivitis Treatment Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Conjunctivitis Treatment Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Conjunctivitis Treatment Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Conjunctivitis Treatment Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Conjunctivitis Treatment Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Conjunctivitis Treatment Drugs Sales by Type (2018-2029)
4.1.1 Global Conjunctivitis Treatment Drugs Sales by Type (2018-2023)
4.1.2 Global Conjunctivitis Treatment Drugs Sales by Type (2024-2029)
4.1.3 Global Conjunctivitis Treatment Drugs Sales Market Share by Type (2018-2029)
4.2 Global Conjunctivitis Treatment Drugs Revenue by Type (2018-2029)
4.2.1 Global Conjunctivitis Treatment Drugs Revenue by Type (2018-2023)
4.2.2 Global Conjunctivitis Treatment Drugs Revenue by Type (2024-2029)
4.2.3 Global Conjunctivitis Treatment Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Conjunctivitis Treatment Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Conjunctivitis Treatment Drugs Sales by Application (2018-2029)
5.1.1 Global Conjunctivitis Treatment Drugs Sales by Application (2018-2023)
5.1.2 Global Conjunctivitis Treatment Drugs Sales by Application (2024-2029)
5.1.3 Global Conjunctivitis Treatment Drugs Sales Market Share by Application (2018-2029)
5.2 Global Conjunctivitis Treatment Drugs Revenue by Application (2018-2029)
5.2.1 Global Conjunctivitis Treatment Drugs Revenue by Application (2018-2023)
5.2.2 Global Conjunctivitis Treatment Drugs Revenue by Application (2024-2029)
5.2.3 Global Conjunctivitis Treatment Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Conjunctivitis Treatment Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bausch & Lomb Inc
6.1.1 Bausch & Lomb Inc Corporation Information
6.1.2 Bausch & Lomb Inc Description and Business Overview
6.1.3 Bausch & Lomb Inc Conjunctivitis Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bausch & Lomb Inc Conjunctivitis Treatment Drugs Product Portfolio
6.1.5 Bausch & Lomb Inc Recent Developments/Updates
6.2 Pfizer Inc
6.2.1 Pfizer Inc Corporation Information
6.2.2 Pfizer Inc Description and Business Overview
6.2.3 Pfizer Inc Conjunctivitis Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer Inc Conjunctivitis Treatment Drugs Product Portfolio
6.2.5 Pfizer Inc Recent Developments/Updates
6.3 Merck & Co., Inc
6.3.1 Merck & Co., Inc Corporation Information
6.3.2 Merck & Co., Inc Description and Business Overview
6.3.3 Merck & Co., Inc Conjunctivitis Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Merck & Co., Inc Conjunctivitis Treatment Drugs Product Portfolio
6.3.5 Merck & Co., Inc Recent Developments/Updates
6.4 Sanofi-Aventis
6.4.1 Sanofi-Aventis Corporation Information
6.4.2 Sanofi-Aventis Description and Business Overview
6.4.3 Sanofi-Aventis Conjunctivitis Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sanofi-Aventis Conjunctivitis Treatment Drugs Product Portfolio
6.4.5 Sanofi-Aventis Recent Developments/Updates
6.5 Boehringer Ingelheim GmbH
6.5.1 Boehringer Ingelheim GmbH Corporation Information
6.5.2 Boehringer Ingelheim GmbH Description and Business Overview
6.5.3 Boehringer Ingelheim GmbH Conjunctivitis Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Boehringer Ingelheim GmbH Conjunctivitis Treatment Drugs Product Portfolio
6.5.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.6 Allergan Inc
6.6.1 Allergan Inc Corporation Information
6.6.2 Allergan Inc Description and Business Overview
6.6.3 Allergan Inc Conjunctivitis Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Allergan Inc Conjunctivitis Treatment Drugs Product Portfolio
6.6.5 Allergan Inc Recent Developments/Updates
6.7 Novartis AG
6.6.1 Novartis AG Corporation Information
6.6.2 Novartis AG Description and Business Overview
6.6.3 Novartis AG Conjunctivitis Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novartis AG Conjunctivitis Treatment Drugs Product Portfolio
6.7.5 Novartis AG Recent Developments/Updates
6.8 Atopix Therapeutics Ltd
6.8.1 Atopix Therapeutics Ltd Corporation Information
6.8.2 Atopix Therapeutics Ltd Description and Business Overview
6.8.3 Atopix Therapeutics Ltd Conjunctivitis Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Atopix Therapeutics Ltd Conjunctivitis Treatment Drugs Product Portfolio
6.8.5 Atopix Therapeutics Ltd Recent Developments/Updates
6.9 Sirion Therapeutics, Inc
6.9.1 Sirion Therapeutics, Inc Corporation Information
6.9.2 Sirion Therapeutics, Inc Description and Business Overview
6.9.3 Sirion Therapeutics, Inc Conjunctivitis Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sirion Therapeutics, Inc Conjunctivitis Treatment Drugs Product Portfolio
6.9.5 Sirion Therapeutics, Inc Recent Developments/Updates
6.10 Akorn Incorporated
6.10.1 Akorn Incorporated Corporation Information
6.10.2 Akorn Incorporated Description and Business Overview
6.10.3 Akorn Incorporated Conjunctivitis Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Akorn Incorporated Conjunctivitis Treatment Drugs Product Portfolio
6.10.5 Akorn Incorporated Recent Developments/Updates
6.11 Actavis Generics
6.11.1 Actavis Generics Corporation Information
6.11.2 Actavis Generics Conjunctivitis Treatment Drugs Description and Business Overview
6.11.3 Actavis Generics Conjunctivitis Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Actavis Generics Conjunctivitis Treatment Drugs Product Portfolio
6.11.5 Actavis Generics Recent Developments/Updates
6.12 Sun Pharma Advanced Research Company Ltd
6.12.1 Sun Pharma Advanced Research Company Ltd Corporation Information
6.12.2 Sun Pharma Advanced Research Company Ltd Conjunctivitis Treatment Drugs Description and Business Overview
6.12.3 Sun Pharma Advanced Research Company Ltd Conjunctivitis Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Sun Pharma Advanced Research Company Ltd Conjunctivitis Treatment Drugs Product Portfolio
6.12.5 Sun Pharma Advanced Research Company Ltd Recent Developments/Updates
6.13 Sinqi
6.13.1 Sinqi Corporation Information
6.13.2 Sinqi Conjunctivitis Treatment Drugs Description and Business Overview
6.13.3 Sinqi Conjunctivitis Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Sinqi Conjunctivitis Treatment Drugs Product Portfolio
6.13.5 Sinqi Recent Developments/Updates
6.14 Santen Pharmaceuticals Co. Ltd
6.14.1 Santen Pharmaceuticals Co. Ltd Corporation Information
6.14.2 Santen Pharmaceuticals Co. Ltd Conjunctivitis Treatment Drugs Description and Business Overview
6.14.3 Santen Pharmaceuticals Co. Ltd Conjunctivitis Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Santen Pharmaceuticals Co. Ltd Conjunctivitis Treatment Drugs Product Portfolio
6.14.5 Santen Pharmaceuticals Co. Ltd Recent Developments/Updates
6.15 Auven Therapeutics
6.15.1 Auven Therapeutics Corporation Information
6.15.2 Auven Therapeutics Conjunctivitis Treatment Drugs Description and Business Overview
6.15.3 Auven Therapeutics Conjunctivitis Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Auven Therapeutics Conjunctivitis Treatment Drugs Product Portfolio
6.15.5 Auven Therapeutics Recent Developments/Updates
6.16 Alcon
6.16.1 Alcon Corporation Information
6.16.2 Alcon Conjunctivitis Treatment Drugs Description and Business Overview
6.16.3 Alcon Conjunctivitis Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Alcon Conjunctivitis Treatment Drugs Product Portfolio
6.16.5 Alcon Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Conjunctivitis Treatment Drugs Industry Chain Analysis
7.2 Conjunctivitis Treatment Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Conjunctivitis Treatment Drugs Production Mode & Process
7.4 Conjunctivitis Treatment Drugs Sales and Marketing
7.4.1 Conjunctivitis Treatment Drugs Sales Channels
7.4.2 Conjunctivitis Treatment Drugs Distributors
7.5 Conjunctivitis Treatment Drugs Customers
8 Conjunctivitis Treatment Drugs Market Dynamics
8.1 Conjunctivitis Treatment Drugs Industry Trends
8.2 Conjunctivitis Treatment Drugs Market Drivers
8.3 Conjunctivitis Treatment Drugs Market Challenges
8.4 Conjunctivitis Treatment Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Conjunctivitis Treatment Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Conjunctivitis Treatment Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Conjunctivitis Treatment Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Conjunctivitis Treatment Drugs Sales (Units) of Key Manufacturers (2018-2023)
Table 5. Global Conjunctivitis Treatment Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Conjunctivitis Treatment Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Conjunctivitis Treatment Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Conjunctivitis Treatment Drugs Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Conjunctivitis Treatment Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Conjunctivitis Treatment Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Conjunctivitis Treatment Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Conjunctivitis Treatment Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Conjunctivitis Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Conjunctivitis Treatment Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Conjunctivitis Treatment Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Conjunctivitis Treatment Drugs Sales by Region (2018-2023) & (Units)
Table 18. Global Conjunctivitis Treatment Drugs Sales Market Share by Region (2018-2023)
Table 19. Global Conjunctivitis Treatment Drugs Sales by Region (2024-2029) & (Units)
Table 20. Global Conjunctivitis Treatment Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Conjunctivitis Treatment Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Conjunctivitis Treatment Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global Conjunctivitis Treatment Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Conjunctivitis Treatment Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Conjunctivitis Treatment Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Conjunctivitis Treatment Drugs Sales by Country (2018-2023) & (Units)
Table 27. North America Conjunctivitis Treatment Drugs Sales by Country (2024-2029) & (Units)
Table 28. North America Conjunctivitis Treatment Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Conjunctivitis Treatment Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Conjunctivitis Treatment Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Conjunctivitis Treatment Drugs Sales by Country (2018-2023) & (Units)
Table 32. Europe Conjunctivitis Treatment Drugs Sales by Country (2024-2029) & (Units)
Table 33. Europe Conjunctivitis Treatment Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Conjunctivitis Treatment Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Conjunctivitis Treatment Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Conjunctivitis Treatment Drugs Sales by Region (2018-2023) & (Units)
Table 37. Asia Pacific Conjunctivitis Treatment Drugs Sales by Region (2024-2029) & (Units)
Table 38. Asia Pacific Conjunctivitis Treatment Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Conjunctivitis Treatment Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Conjunctivitis Treatment Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Conjunctivitis Treatment Drugs Sales by Country (2018-2023) & (Units)
Table 42. Latin America Conjunctivitis Treatment Drugs Sales by Country (2024-2029) & (Units)
Table 43. Latin America Conjunctivitis Treatment Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Conjunctivitis Treatment Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Conjunctivitis Treatment Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Conjunctivitis Treatment Drugs Sales by Country (2018-2023) & (Units)
Table 47. Middle East & Africa Conjunctivitis Treatment Drugs Sales by Country (2024-2029) & (Units)
Table 48. Middle East & Africa Conjunctivitis Treatment Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Conjunctivitis Treatment Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Conjunctivitis Treatment Drugs Sales (Units) by Type (2018-2023)
Table 51. Global Conjunctivitis Treatment Drugs Sales (Units) by Type (2024-2029)
Table 52. Global Conjunctivitis Treatment Drugs Sales Market Share by Type (2018-2023)
Table 53. Global Conjunctivitis Treatment Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Conjunctivitis Treatment Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Conjunctivitis Treatment Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Conjunctivitis Treatment Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global Conjunctivitis Treatment Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Conjunctivitis Treatment Drugs Price (US$/Unit) by Type (2018-2023)
Table 59. Global Conjunctivitis Treatment Drugs Price (US$/Unit) by Type (2024-2029)
Table 60. Global Conjunctivitis Treatment Drugs Sales (Units) by Application (2018-2023)
Table 61. Global Conjunctivitis Treatment Drugs Sales (Units) by Application (2024-2029)
Table 62. Global Conjunctivitis Treatment Drugs Sales Market Share by Application (2018-2023)
Table 63. Global Conjunctivitis Treatment Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Conjunctivitis Treatment Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Conjunctivitis Treatment Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Conjunctivitis Treatment Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global Conjunctivitis Treatment Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Conjunctivitis Treatment Drugs Price (US$/Unit) by Application (2018-2023)
Table 69. Global Conjunctivitis Treatment Drugs Price (US$/Unit) by Application (2024-2029)
Table 70. Bausch & Lomb Inc Corporation Information
Table 71. Bausch & Lomb Inc Description and Business Overview
Table 72. Bausch & Lomb Inc Conjunctivitis Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Bausch & Lomb Inc Conjunctivitis Treatment Drugs Product
Table 74. Bausch & Lomb Inc Recent Developments/Updates
Table 75. Pfizer Inc Corporation Information
Table 76. Pfizer Inc Description and Business Overview
Table 77. Pfizer Inc Conjunctivitis Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Pfizer Inc Conjunctivitis Treatment Drugs Product
Table 79. Pfizer Inc Recent Developments/Updates
Table 80. Merck & Co., Inc Corporation Information
Table 81. Merck & Co., Inc Description and Business Overview
Table 82. Merck & Co., Inc Conjunctivitis Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Merck & Co., Inc Conjunctivitis Treatment Drugs Product
Table 84. Merck & Co., Inc Recent Developments/Updates
Table 85. Sanofi-Aventis Corporation Information
Table 86. Sanofi-Aventis Description and Business Overview
Table 87. Sanofi-Aventis Conjunctivitis Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Sanofi-Aventis Conjunctivitis Treatment Drugs Product
Table 89. Sanofi-Aventis Recent Developments/Updates
Table 90. Boehringer Ingelheim GmbH Corporation Information
Table 91. Boehringer Ingelheim GmbH Description and Business Overview
Table 92. Boehringer Ingelheim GmbH Conjunctivitis Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Boehringer Ingelheim GmbH Conjunctivitis Treatment Drugs Product
Table 94. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 95. Allergan Inc Corporation Information
Table 96. Allergan Inc Description and Business Overview
Table 97. Allergan Inc Conjunctivitis Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Allergan Inc Conjunctivitis Treatment Drugs Product
Table 99. Allergan Inc Recent Developments/Updates
Table 100. Novartis AG Corporation Information
Table 101. Novartis AG Description and Business Overview
Table 102. Novartis AG Conjunctivitis Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Novartis AG Conjunctivitis Treatment Drugs Product
Table 104. Novartis AG Recent Developments/Updates
Table 105. Atopix Therapeutics Ltd Corporation Information
Table 106. Atopix Therapeutics Ltd Description and Business Overview
Table 107. Atopix Therapeutics Ltd Conjunctivitis Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Atopix Therapeutics Ltd Conjunctivitis Treatment Drugs Product
Table 109. Atopix Therapeutics Ltd Recent Developments/Updates
Table 110. Sirion Therapeutics, Inc Corporation Information
Table 111. Sirion Therapeutics, Inc Description and Business Overview
Table 112. Sirion Therapeutics, Inc Conjunctivitis Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Sirion Therapeutics, Inc Conjunctivitis Treatment Drugs Product
Table 114. Sirion Therapeutics, Inc Recent Developments/Updates
Table 115. Akorn Incorporated Corporation Information
Table 116. Akorn Incorporated Description and Business Overview
Table 117. Akorn Incorporated Conjunctivitis Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Akorn Incorporated Conjunctivitis Treatment Drugs Product
Table 119. Akorn Incorporated Recent Developments/Updates
Table 120. Actavis Generics Corporation Information
Table 121. Actavis Generics Description and Business Overview
Table 122. Actavis Generics Conjunctivitis Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Actavis Generics Conjunctivitis Treatment Drugs Product
Table 124. Actavis Generics Recent Developments/Updates
Table 125. Sun Pharma Advanced Research Company Ltd Corporation Information
Table 126. Sun Pharma Advanced Research Company Ltd Description and Business Overview
Table 127. Sun Pharma Advanced Research Company Ltd Conjunctivitis Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Sun Pharma Advanced Research Company Ltd Conjunctivitis Treatment Drugs Product
Table 129. Sun Pharma Advanced Research Company Ltd Recent Developments/Updates
Table 130. Sinqi Corporation Information
Table 131. Sinqi Description and Business Overview
Table 132. Sinqi Conjunctivitis Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Sinqi Conjunctivitis Treatment Drugs Product
Table 134. Sinqi Recent Developments/Updates
Table 135. Santen Pharmaceuticals Co. Ltd Corporation Information
Table 136. Santen Pharmaceuticals Co. Ltd Description and Business Overview
Table 137. Santen Pharmaceuticals Co. Ltd Conjunctivitis Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Santen Pharmaceuticals Co. Ltd Conjunctivitis Treatment Drugs Product
Table 139. Santen Pharmaceuticals Co. Ltd Recent Developments/Updates
Table 140. Auven Therapeutics Corporation Information
Table 141. Auven Therapeutics Description and Business Overview
Table 142. Auven Therapeutics Conjunctivitis Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Auven Therapeutics Conjunctivitis Treatment Drugs Product
Table 144. Auven Therapeutics Recent Developments/Updates
Table 145. Alcon Corporation Information
Table 146. Alcon Description and Business Overview
Table 147. Alcon Conjunctivitis Treatment Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Alcon Conjunctivitis Treatment Drugs Product
Table 149. Alcon Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Conjunctivitis Treatment Drugs Distributors List
Table 153. Conjunctivitis Treatment Drugs Customers List
Table 154. Conjunctivitis Treatment Drugs Market Trends
Table 155. Conjunctivitis Treatment Drugs Market Drivers
Table 156. Conjunctivitis Treatment Drugs Market Challenges
Table 157. Conjunctivitis Treatment Drugs Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Conjunctivitis Treatment Drugs
Figure 2. Global Conjunctivitis Treatment Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Conjunctivitis Treatment Drugs Market Share by Type in 2022 & 2029
Figure 4. Antibiotic Product Picture
Figure 5. Mast Cell Stabilizer Product Picture
Figure 6. Corticosteroids Product Picture
Figure 7. Others Product Picture
Figure 8. Global Conjunctivitis Treatment Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Conjunctivitis Treatment Drugs Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Medical Institutions
Figure 13. Others
Figure 14. Global Conjunctivitis Treatment Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Conjunctivitis Treatment Drugs Market Size (2018-2029) & (US$ Million)
Figure 16. Global Conjunctivitis Treatment Drugs Sales (2018-2029) & (Units)
Figure 17. Global Conjunctivitis Treatment Drugs Average Price (US$/Unit) & (2018-2029)
Figure 18. Conjunctivitis Treatment Drugs Report Years Considered
Figure 19. Conjunctivitis Treatment Drugs Sales Share by Manufacturers in 2022
Figure 20. Global Conjunctivitis Treatment Drugs Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Conjunctivitis Treatment Drugs Players: Market Share by Revenue in 2022
Figure 22. Conjunctivitis Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Conjunctivitis Treatment Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Conjunctivitis Treatment Drugs Sales Market Share by Country (2018-2029)
Figure 25. North America Conjunctivitis Treatment Drugs Revenue Market Share by Country (2018-2029)
Figure 26. United States Conjunctivitis Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Conjunctivitis Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Conjunctivitis Treatment Drugs Sales Market Share by Country (2018-2029)
Figure 29. Europe Conjunctivitis Treatment Drugs Revenue Market Share by Country (2018-2029)
Figure 30. Germany Conjunctivitis Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Conjunctivitis Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Conjunctivitis Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Conjunctivitis Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Conjunctivitis Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Conjunctivitis Treatment Drugs Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Conjunctivitis Treatment Drugs Revenue Market Share by Region (2018-2029)
Figure 37. China Conjunctivitis Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Conjunctivitis Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Conjunctivitis Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Conjunctivitis Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Conjunctivitis Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Conjunctivitis Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Conjunctivitis Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Conjunctivitis Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Conjunctivitis Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Conjunctivitis Treatment Drugs Sales Market Share by Country (2018-2029)
Figure 47. Latin America Conjunctivitis Treatment Drugs Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Conjunctivitis Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Conjunctivitis Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Conjunctivitis Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Conjunctivitis Treatment Drugs Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Conjunctivitis Treatment Drugs Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Conjunctivitis Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Conjunctivitis Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Conjunctivitis Treatment Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Conjunctivitis Treatment Drugs by Type (2018-2029)
Figure 57. Global Revenue Market Share of Conjunctivitis Treatment Drugs by Type (2018-2029)
Figure 58. Global Conjunctivitis Treatment Drugs Price (US$/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Conjunctivitis Treatment Drugs by Application (2018-2029)
Figure 60. Global Revenue Market Share of Conjunctivitis Treatment Drugs by Application (2018-2029)
Figure 61. Global Conjunctivitis Treatment Drugs Price (US$/Unit) by Application (2018-2029)
Figure 62. Conjunctivitis Treatment Drugs Value Chain
Figure 63. Conjunctivitis Treatment Drugs Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 貧血治療薬の世界市場2023年：サプリメント、抗生物質、免疫抑制剤、骨髄刺激剤、コルチコステロイド、遺伝子治療、鉄キレート剤
  • 咳喘息（CVA）治療薬のグローバル市場展望 2023年-2029年：気管支拡張剤、ロイコトリエン拮抗剤、肥満細胞安定剤、コルチコステロイド、モノクローナル抗体
  • 脳転移治療薬の世界市場2023年：抗けいれん薬、コルチコステロイド、化学療法薬、その他
  • 気管支炎治療薬のグローバル市場展望 2023年-2029年：抗生物質、抗アレルギー薬（抗ヒスタミン薬）、気管支拡張薬、粘液溶解薬、その他
  • 急性気管支炎治療薬のグローバル市場展望 2023年-2029年：抗生物質、抗アレルギー薬（抗ヒスタミン薬）、気管支拡張薬、粘液溶解薬、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8727 )"結膜炎治療薬の世界市場2023年：抗生物質、肥満細胞安定剤、コルチコステロイド、その他" (英文：Global Conjunctivitis Treatment Drugs Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。